New $16,000 Postpartum Depression Drug Sparks Debate Over Healthcare Accessibility
Explore the complexities surrounding Zurzuvae, the groundbreaking postpartum depression pill with a hefty price tag. Understand its benefits, the concerns about insurance coverage, and the broader implications for mental health care accessibility.